US Stock MarketDetailed Quotes

Bicycle Therapeutics (BCYC)

Watchlist
  • 4.980
  • +0.080+1.63%
Close Apr 8 16:00 ET
  • 4.980
  • 0.0000.00%
Post 17:47 ET
347.14MMarket Cap-1.58P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bicycle Therapeutics (BCYC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
105.77%72.59M
1,193.28%47.96M
338.49%11.73M
-68.81%2.92M
-48.91%9.98M
30.76%35.28M
-30.44%3.71M
-50.00%2.68M
-17.86%9.36M
298.90%19.53M
Operating revenue
105.77%72.59M
1,193.28%47.96M
338.49%11.73M
-68.81%2.92M
-48.91%9.98M
30.76%35.28M
-30.44%3.71M
-50.00%2.68M
-17.86%9.36M
298.90%19.53M
Cost of revenue
Gross profit
Operating expense
31.04%320.3M
2.56%72.61M
16.98%77.44M
60.88%90.27M
55.86%79.98M
12.68%244.43M
17.33%70.8M
19.42%66.2M
2.21%56.11M
10.97%51.32M
Selling and administrative expenses
11.98%80.02M
-0.85%20.84M
6.02%19.02M
19.86%19.24M
27.17%20.92M
18.26%71.46M
34.35%21.02M
15.23%17.94M
5.75%16.05M
17.23%16.45M
-General and administrative expense
11.98%80.02M
-0.85%20.84M
6.02%19.02M
19.86%19.24M
27.17%20.92M
18.26%71.46M
34.35%21.02M
15.23%17.94M
5.75%16.05M
17.23%16.45M
Research and development costs
38.92%240.28M
4.00%51.77M
21.05%58.43M
77.31%71.03M
69.40%59.06M
10.52%172.97M
11.37%49.78M
21.06%48.27M
0.85%40.06M
8.24%34.86M
Operating profit
-18.44%-247.72M
63.25%-24.66M
-3.43%-65.71M
-86.85%-87.35M
-120.23%-70.01M
-10.11%-209.15M
-21.96%-67.09M
-26.84%-63.53M
-7.46%-46.75M
23.13%-31.79M
Net non-operating interest income expense
-13.20%28.26M
-43.23%5.82M
-36.91%6.66M
6.75%7.42M
74.12%8.36M
203.14%32.55M
87.88%10.25M
232.70%10.55M
77,322.22%6.95M
126.45%4.8M
Non-operating interest income
-16.98%28.46M
-42.97%5.88M
-36.69%6.7M
-3.87%7.47M
49.61%8.41M
144.85%34.28M
64.17%10.3M
165.57%10.58M
857.39%7.77M
92.01%5.62M
Non-operating interest expense
-88.09%206K
9.62%57K
33.33%44K
-93.45%54K
-93.79%51K
-46.98%1.73M
-93.66%52K
-95.95%33K
0.37%824K
1.61%821K
Other net income (expense)
-76.70%653K
-101.31%-51K
112.41%158K
637.62%745K
-380.28%-199K
571.89%2.8M
2,033.33%3.9M
-78.29%-1.27M
-74.10%101K
115.67%71K
Gain on sale of security
190.82%653K
91.08%-51K
149.53%158K
637.62%745K
-380.28%-199K
-21.04%-719K
-412.57%-572K
55.32%-319K
-74.10%101K
115.67%71K
Special income (charges)
--0
--0
--0
----
----
--3.52M
--4.48M
---954K
----
----
-Less:Other special charges
----
----
----
----
----
---3.52M
---4.48M
--954K
----
----
Other non- operating income (expenses)
----
----
----
----
----
--4.48M
----
----
----
----
Income before tax
-25.90%-218.81M
64.32%-18.89M
-8.56%-58.9M
-99.47%-79.18M
-129.78%-61.84M
3.02%-173.8M
-8.52%-52.94M
-13.91%-54.25M
7.94%-39.7M
32.18%-26.91M
Income tax
103.19%152K
216.91%1.27M
105.95%205K
-300.87%-231K
-210.57%-1.09M
-427.04%-4.77M
-438.13%-1.08M
-251.76%-3.45M
122.24%115K
43.37%-350K
Net income
-29.54%-218.96M
61.13%-20.15M
-16.33%-59.1M
-98.31%-78.95M
-128.72%-60.75M
6.44%-169.03M
-5.61%-51.85M
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
Net income continuous Operations
-29.54%-218.96M
61.13%-20.15M
-16.33%-59.1M
-98.31%-78.95M
-128.72%-60.75M
6.44%-169.03M
-5.61%-51.85M
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
Minority interest income
Net income attributable to the parent company
-29.54%-218.96M
61.13%-20.15M
-16.33%-59.1M
-98.31%-78.95M
-128.72%-60.75M
6.44%-169.03M
-5.61%-51.85M
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-29.54%-218.96M
61.13%-20.15M
-16.33%-59.1M
-98.31%-78.95M
-128.72%-60.75M
6.44%-169.03M
-5.61%-51.85M
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
Basic earnings per share
-8.97%-3.16
61.33%-0.29
-14.86%-0.85
-48.05%-1.14
-41.94%-0.88
42.91%-2.9
35.34%-0.75
41.27%-0.74
45.39%-0.77
52.31%-0.62
Diluted earnings per share
-8.97%-3.16
61.33%-0.29
-14.86%-0.85
-48.05%-1.14
-41.94%-0.88
42.91%-2.9
35.34%-0.75
41.27%-0.74
45.39%-0.77
52.31%-0.62
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 105.77%72.59M1,193.28%47.96M338.49%11.73M-68.81%2.92M-48.91%9.98M30.76%35.28M-30.44%3.71M-50.00%2.68M-17.86%9.36M298.90%19.53M
Operating revenue 105.77%72.59M1,193.28%47.96M338.49%11.73M-68.81%2.92M-48.91%9.98M30.76%35.28M-30.44%3.71M-50.00%2.68M-17.86%9.36M298.90%19.53M
Cost of revenue
Gross profit
Operating expense 31.04%320.3M2.56%72.61M16.98%77.44M60.88%90.27M55.86%79.98M12.68%244.43M17.33%70.8M19.42%66.2M2.21%56.11M10.97%51.32M
Selling and administrative expenses 11.98%80.02M-0.85%20.84M6.02%19.02M19.86%19.24M27.17%20.92M18.26%71.46M34.35%21.02M15.23%17.94M5.75%16.05M17.23%16.45M
-General and administrative expense 11.98%80.02M-0.85%20.84M6.02%19.02M19.86%19.24M27.17%20.92M18.26%71.46M34.35%21.02M15.23%17.94M5.75%16.05M17.23%16.45M
Research and development costs 38.92%240.28M4.00%51.77M21.05%58.43M77.31%71.03M69.40%59.06M10.52%172.97M11.37%49.78M21.06%48.27M0.85%40.06M8.24%34.86M
Operating profit -18.44%-247.72M63.25%-24.66M-3.43%-65.71M-86.85%-87.35M-120.23%-70.01M-10.11%-209.15M-21.96%-67.09M-26.84%-63.53M-7.46%-46.75M23.13%-31.79M
Net non-operating interest income expense -13.20%28.26M-43.23%5.82M-36.91%6.66M6.75%7.42M74.12%8.36M203.14%32.55M87.88%10.25M232.70%10.55M77,322.22%6.95M126.45%4.8M
Non-operating interest income -16.98%28.46M-42.97%5.88M-36.69%6.7M-3.87%7.47M49.61%8.41M144.85%34.28M64.17%10.3M165.57%10.58M857.39%7.77M92.01%5.62M
Non-operating interest expense -88.09%206K9.62%57K33.33%44K-93.45%54K-93.79%51K-46.98%1.73M-93.66%52K-95.95%33K0.37%824K1.61%821K
Other net income (expense) -76.70%653K-101.31%-51K112.41%158K637.62%745K-380.28%-199K571.89%2.8M2,033.33%3.9M-78.29%-1.27M-74.10%101K115.67%71K
Gain on sale of security 190.82%653K91.08%-51K149.53%158K637.62%745K-380.28%-199K-21.04%-719K-412.57%-572K55.32%-319K-74.10%101K115.67%71K
Special income (charges) --0--0--0----------3.52M--4.48M---954K--------
-Less:Other special charges -----------------------3.52M---4.48M--954K--------
Other non- operating income (expenses) ----------------------4.48M----------------
Income before tax -25.90%-218.81M64.32%-18.89M-8.56%-58.9M-99.47%-79.18M-129.78%-61.84M3.02%-173.8M-8.52%-52.94M-13.91%-54.25M7.94%-39.7M32.18%-26.91M
Income tax 103.19%152K216.91%1.27M105.95%205K-300.87%-231K-210.57%-1.09M-427.04%-4.77M-438.13%-1.08M-251.76%-3.45M122.24%115K43.37%-350K
Net income -29.54%-218.96M61.13%-20.15M-16.33%-59.1M-98.31%-78.95M-128.72%-60.75M6.44%-169.03M-5.61%-51.85M-1.81%-50.8M6.55%-39.81M32.00%-26.56M
Net income continuous Operations -29.54%-218.96M61.13%-20.15M-16.33%-59.1M-98.31%-78.95M-128.72%-60.75M6.44%-169.03M-5.61%-51.85M-1.81%-50.8M6.55%-39.81M32.00%-26.56M
Minority interest income
Net income attributable to the parent company -29.54%-218.96M61.13%-20.15M-16.33%-59.1M-98.31%-78.95M-128.72%-60.75M6.44%-169.03M-5.61%-51.85M-1.81%-50.8M6.55%-39.81M32.00%-26.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -29.54%-218.96M61.13%-20.15M-16.33%-59.1M-98.31%-78.95M-128.72%-60.75M6.44%-169.03M-5.61%-51.85M-1.81%-50.8M6.55%-39.81M32.00%-26.56M
Basic earnings per share -8.97%-3.1661.33%-0.29-14.86%-0.85-48.05%-1.14-41.94%-0.8842.91%-2.935.34%-0.7541.27%-0.7445.39%-0.7752.31%-0.62
Diluted earnings per share -8.97%-3.1661.33%-0.29-14.86%-0.85-48.05%-1.14-41.94%-0.8842.91%-2.935.34%-0.7541.27%-0.7445.39%-0.7752.31%-0.62
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.68%
Sample Name
Sample Code
 +16.26%
Sample Name
Sample Code
 +13.08%
4
United Sts Brent Oil Fd Lp Unit
BNO
+10.72%
5
ProShares Ultra Energy
DIG
+9.35%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.90%
Sample Name
Sample Code
 +14.44%
Sample Name
Sample Code
 +13.72%
4
ASE Technology
ASX
+11.35%
5
Kingsoft Cloud
KC
+9.51%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran situation has reached a major turning point as Trump announced a two-week suspension of military actions against Iran, with both Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -